Skip to content

Buy Ajanta Pharmaceuticals; target of Rs 1505: ICICI Direct

ICICI Direct is bullish on Ajanta Pharmaceuticals recommended buy rating on the stock with a target price of Rs 1505 in its research report dated November 04, 2022.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish